C1 esterase inhibitor deficiency
-> hereditary angioedema. ACE inhibitors are contraindicated.
C3 deficiency
-> severe, recurrent pyogenic sinus and respiratory tract infections. Increased susceptibility to type III hypersensitivity reactions.
C5-C9 deficiencies
-> recurrent Neisseria bacteremia.
DAF (GPI anchored enzyme) deficiency
-> complement-mediated lysis of RBCs and paroxysmal nocturnal hemoglobinuria (PNH).